Filing Details
- Accession Number:
- 0001232524-18-000059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-07 16:10:04
- Reporting Period:
- 2018-03-05
- Accepted Time:
- 2018-03-07 16:10:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601583 | P. Matthew Young | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2018-03-05 | 1,348 | $143.39 | 41,017 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2018-03-06 | 800 | $142.06 | 40,217 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2018-03-06 | 352 | $143.04 | 39,865 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $141.4500 to $142.4200. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $142.6400 to $143.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Billionaire Hedge Funds
